VERU
Veru IncNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$38.84M
P/E Ratio
—
EPS
$-1.21
Beta
-1.34
52W High
$7.40
52W Low
$2.06
50-Day MA
$2.40
200-Day MA
$3.24
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
117.65
PEG Ratio
3.60
About Veru Inc
Veru Inc., an oncology biopharmaceutical company, focuses on the development of drugs for the treatment of cancers. The company is headquartered in Miami, Florida.
Fundamentals
| Revenue (TTM) | $16.89M |
| Gross Profit (TTM) | $5.85M |
| EBITDA | $-29.90M |
| Operating Margin | 0.00% |
| Return on Equity | -60.30% |
| Return on Assets | -42.90% |
| Revenue/Share (TTM) | $1.15 |
| Book Value | $2.31 |
| Price-to-Book | 1.05 |
| Price-to-Sales (TTM) | 1.79 |
| EV/Revenue | 1.414 |
| EV/EBITDA | 42.93 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 18.30% |
| Shares Outstanding | $16.05M |
| Float | $13.48M |
| % Insiders | 9.78% |
| % Institutions | 24.24% |
Historical Volatility
HV 10-Day
46.16%
HV 20-Day
47.81%
HV 30-Day
44.26%
HV 60-Day
55.91%
HV Rank
7.9%
Volatility is currently expanding
Analyst Ratings
Consensus ($25.00 target)
2
BuyData last updated: 4/15/2026